Viewing Study NCT02247869


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-28 @ 10:04 AM
Study NCT ID: NCT02247869
Status: COMPLETED
Last Update Posted: 2018-02-09
First Post: 2014-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module